Neointima formation in a restenosis model is suppressed in midkine- deficient mice

Journal of Clinical Investigation

Volumn 105, Issue 4, 2000, Pages 489-495

  Horiba, Mitsuru ^a,b   Kadomatsu, Kenji ^a   Nakamura, Eishin ^a,b   Muramatsu, Hisako ^a   Ikematsu, Shinya ^c   Sakuma, Sadatoshi ^c   Hayashi, Kenji ^a   Yuzawa, Yukio ^a   Matsuo, Seiichi ^a   Kuzuya, Masafumi ^b   Kaname, Tadashi ^a,d   Hirai, Makoto ^b   Saito, Hidehiko ^b   Muramatsu, Takashi ^a,b  

^a Department of Biochemistry ^*  (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Meiji Cell Technology Center   (Japan)

^d KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MIDKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; ATHEROSCLEROSIS; IMMUNOHISTOCHEMISTRY; LEUKOCYTE MIGRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESTENOSIS;

EID: 0033994614     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7208     Document Type: Article

References (39)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801-809.
2. Schwartz, S.M., deBlois D., and O'Brien, E.R.M. 1995. The intima. Soil for atherosclerosis and rostenosis Circ. Res. 77:445-465.
3. Ferns, G.A.A., et al. 1991. Inhibition of neointima smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 253:1129-1132.
4. Nabel, E.G., et al. 1993. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J. Clin. Invest. 91:1822-1829.
5. Banai, S., et al. 1998. PDGF-receptor tyrosine kinase blocker AG 1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation. 97:1960-1969.
6. Lindner, V., and Reidy, M.A. 1991. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA. 88:3739-3743.
7. Boring, L., Gosling, J., Clearly, M., and Charo, I.F. 1998. Decreased lesion formation in CCR2 / mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:894-897.
8. Kadomatsu, K., Tomomura, M., and Muramatsu, T. 1988. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation of atherosclerosis. Biochem. Biophys. Res. Commun. 151:1312-1318.
9. Iwasaki, W., et al. 1997. Solution structure of midkine, a new heparin-binding growth factor EMBO J. 16:6936-6946.
10. Rauvala, H. 1989. An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J. 8:2933-2941.
11. Merenmies, J., and Rauvala, H. 1990. Molecular cloning of the 18-kDa growth-associated protein of developing brain. J. Biol. Chem. 265:16721-16724.
12. Li, Y.S., et al. 1990. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science. 250:1690-1694.
13. Kadomatsu, K., Huang, R.-P., Suganuma, T., Murata, F., and MuramatSu, T. 1990. A retinoic acid responsive gene MK found in the terarocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J. Cell Biol. 110:607-616.
14. Peng, H.B., et al. 1995. The role of heparin-binding growth-associated molecule (HB-GAM) in the postsynaptic induction in cultured muscle cells. J. Neurosci. 15:3027-3038.
15. Nakamura, E., et al. 1998. Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behavior. Genes Cells 3:811-822.
16. Nakagawara, A., et al. 1995. Differential expression of pletotrophin and midkine in advanced neuroblastomas. Cancer Res. 55:1792-1797.
17. Czubayko, F., Shulte, A.M., Berchem, G.J, and Wellstein, A. 1996. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiorrophin. Proc. Natl. Acad. Sci. USA. 93:14753-14758.
18. Clowes, A.W., Reidy, M.A., and Clowes, M.M. 1983. Mechanisms of stenosis after arterial injury. Lab. Invest. 49:208-215.
19. Kadomatsu, K., et al. 1997. Midkine induces the transformation of N1113T3 cells. Br. J. Cancer. 75:354-359.
20. Kumar, A., and Lindner, V. 1997. Remodeling with neointima formation in the mouse carotid artery after cessation of blond flow. Arterioscler. Thromb. Vasc. Biol. 47:2238-2244.
21. Tsutsui, J., Uehara, K., Kadomatsu, K., Matsubara, S , and Muramatsu, T. 1991. A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. Biochem. Biophys Res. Commun. 176:792-797.
22. Muramatsu, H., and Muramatsu, T. 1991. Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. Biochem. Biophys. Res. Commun. 176:792-797.
23. Take, M., et al. 1994. Identification of nucleolin as a binding protein for midkine (MK) and heparin-binding growth associated molecule (HB-GAM). J. Biochem. (Tokyo). 116:1063-1068.
24. Ye, C., et al. 1998. Expression of midkine in the early stages of carcinogenesis in human colorectal cancer. Br. J. Cancer. 79:179-184.
25. Yasuhara, O., et al. 1993. Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease. Biochem. Biophys. Res. Commun. 192:246-251.
26. Xie, B., Dong, Z., and Fidler, I.J. 1994. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J. Immunol. 152:3637-3644.
27. Brown, S.L., Lundgren, C.H., Nordt, T., and Fujii, S. 1994. Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis. Cardiovasc. Res. 28:1815-1820.
28. Basson, C.T., Kocher, O., Basson, M.D., Asis, A., and Madri, J.A. 1992. Differenrial modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-β1 correlates with reciprocal effects on cell migration J. Cell. Physiol. 153:118-128.
29. Fukazawa, H., Nakano, S., Mizuno, S., and Uehara, Y. 1996. Inhibitors of anchorage-independent growth affect the growth of transformed cells on poly(2-hydroxyethyl methacrylate)-coated surfaces. Int. J. Cancer. 67:876-882.
30. Kumar, A., Hoover, J.L., Simmons, C.A., Lindner, V., and Shebuski, R.J. 1997. Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation. 96:4333-4342.
31. Takada, T., Muramatsu, H., Song, X.-J., Torii, S., and Muramatsu, T. 1997. Midkine, a retinoic acid-inducible heparin-biding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J. Biochem. (Tokyo). 122:453-458.
32. Maeda, N., and Noda, M. 1998. Involvement of receptor-like protein tyrosine phosphatase ζ/RPTPβ and its ligand pleiotrophin/HB-GAM in neuronal migration. J. Cell Biol. 142:203-216.
33. Imai, S., et al. 1998. Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J. Cell Biol. 143:1113-1128.
34. Olson, N.E., Chao, S., Lindner, V., and Reidy. M.A. 1992. Intimal smooth muscle cell proliferation after balloon catheter injury. The role of basic fibroblast growth factor. Am. J. Pathol. 140:1017-1023.
35. Ohyama, Y., Miyamoto, K., Minamino, N., and Matsuo, H. 1994 Isolation and identification of midkine and pleiotrophin in bovine follicular fluid. Mol. Cell. Endocrinol. 105:203-208.
36. Ellis, S.G., Roubin, G.S., Wilentz, J., Douglas, J.S., Jr., and King, S.B. 1989. Effect of 18-to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am. Heart J. 117:777-782.
37. Emanuelsson, H., et al. 1995. Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic testenosis. Circulation 91:1689-1696.
38. The Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. 1992. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Circulation. 86:100-110.
39. Kaneda, N., Talukder, A.H., Nishiyama, H., Koizumi, S., and Muramatsu, T. 1996. Midkine, a heparin-binding growth/differentiation factor, exhibits nerve cell adhesion and guidance activity for neurite outgrowth in vitro. J. Biochem (Tokyo). 119:1150-1156.